CD8+ T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis

Journal of Clinical Investigation

Volumn 106, Issue 1, 2000, Pages 47-53

  Fiorillo, Maria T ^a   Maragno, Monica ^a   Butler, Richard ^b   Dupuis, Maria L ^c   Sorrentino, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033935853     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9295     Document Type: Article

References (33)

1. Brewerton, D.A., et al. 1973. Ankylosing spondylitis and HL-A 27. Lancet. 1:904-907.
2. Schlosstein, L., Terasaki, P.I., Bluestone, R., and Pearson, C.M. 1973. High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Eng. J. Med. 288:704-706.
3. Lopez de Castro, J.A. 1998. The pathogenetic role of HLA-B27 in chronic arthritis. Curr. Opin. Immunol. 10:59-66.
4. D'Amato, M., et al. 1995. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25:3199-3201.
5. Gonzales-Roces, S., et al. 1997. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 49:116-123.
6. Breur-Vriesendorp, B.S., Dekker-Saeys, A.J., and Ivanyi, P. 1987. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of various B27 molecules. Ann. Rheum. Dis. 46:353-356.
7. Del Porto, P., et al. 1994. Identification of a novel HLA-H27 subtype by restriction analysis of a cytotoxic γδT cell clone. J. Immunol. 153:3093-3100.
8. Taurog, J.D. 1998. HLA-B27 subtypes, disease susceptibility, and peptide binding specificity. In The spondyloarthritides. A. Calin and J.D. Taurog, editors. Oxford University Press. Oxford, United Kingdom 267-274.
9. Benjamin, R., and Parham, P. 1990. Guilty by association: HLA-B27 and ankylosing spondylitis. Immunol. Today. 11:137-142.
10. Fiorillo, M.T., et al. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 27:368-373.
11. Todd, J.A., Bell, J.I., and McDevitt, H.O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:599-604.
12. Gregersen, P.K., Silver, J., and Winchester, R.J. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-1213.
13. Gao, X.M., Wordsworth, P., and McMichael, A. 1994. Collagen-specific cytoroxic T lymphocyte responses in patients with ankylosing spondylitis and reactive arthritis. Eur. J. Immunol. 24:1665-1670.
14. Ugrinovic, S., Mertz, A., Wu, P., Braun, J., and Sieper, J. 1997. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J. Immunol. 159:5715-5723.
15. Hermann, E., Yu, D.T.Y., Meyer zum Buschenfelde, K.H., and Fleischer, B. 1993. HLA-B27-restricted T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 342:646-650.
16. Huang, F., et al. 1996. A patient-detived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences. Infect. Immun. 64:120-127.
17. Rotzschke, O., et al. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics. 39:74-77.
18. 116 that differentiates the ankylosing spondylitis associated HLA-B*2705 from the non associated HLA-B*2709 subtype influences peptide-specific CD8 T cells recognition. Eur. J. Immunol. 28:2508-2516.
19. Sreedharan, S.P., Patel, D.R, Huang, J.X., and Goetzl, E.J. 1993. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193:546-553.
20. Sreedharan, S.P., Huang, J.X., Cheung, M.C., and Goetzl, E.J. 1995. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl. Acad. Sci. USA. 92:2939-2943.
21. Ellis, S.A., Taylor, C., and McMichael, A. 1982. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immunol. 5:49-53.
22. McCutcheon, M., et al. 1997. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods. 210:149-166.
23. Brooks, J.M., Murray, R.J., Thomas, W.A., Kurilla, M.G., and Rickinson, A.B. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879-887
24. Bowness, P., Allen, R.L., and McMichael, A.J. 1994. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27. Eur. J. Immunol. 24:2357-2363.
25. Kaplan, E.L., and Meier, P. 1958. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 53:457-481.
26. Sospedra, M., et al. 1998. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanism in tolerance towards peripheral antigens. J. Immunol. 161:5918-5929.
27. Klein, L., Klugmann, M., Klaus-Armin, N., Tuohy, V.K., and Kyewski, B. 2000. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6:56-61.
28. Kersh, G., and Allen, P.M. 1996. Essential flexibility in the T-cell recognition of antigen. Nature. 380:495-498.
29. Xin, Z., et al. 1997. Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets. Regul. Pept 72:41-54.
30. Scotet, E., et al. 1999. Frequent enrichment for CD8 T cell reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur. J. Immunol. 29:973-985.
31. Scotet, E., et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184:1791-1800.
32. Groos, D.M., et al. 1998. Identification of LFA-1 as candidate autoantigen in treatment-resistant Lyme arthritis. Science. 281:703-706.
33. Matsumoto, I., Staub, A., Benoist, C., and Mathis, D. 1999. Arthritis provoked by linked T and B cell recognition of a glycolitic enzyme. Science. 286:1732-1735.